Search clinical trials for: Skin Irritation in elderly Alzheimer's subjects

Total 462599 results

Teikoku Pharma USA, Inc.

Completed

Study in Elderly Alzheimer's Patients to Assess Skin Tolerability, Irritation With 3, 7-Day Applications of DTP-System (DTP-System)

Irritation/Irritant

United States
Casa di Cura Privata del Policlinico SpA
Westfälische Wilhelms-Universität Münster; Campus Neurológico Sénior; Carol Davila... and other collaborators

Completed

Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases

Quality of Life | Parkinson Disease | Neurodegenerative Diseases | Alzheimer Disease

Italy
Calibr, a division of Scripps Research
Alzheimer's Drug Discovery Foundation; Michael J. Fox Foundation for Parkinson...

Recruiting

Study to Assess PDM608 in Healthy Adult Subjects

Parkinson Disease

United States
Centre Hospitalier Universitaire de Nice

Recruiting

Nalysis of the Periodontal Microbiota in Elderly Subjects With and Without Alzheimer's Disease: a Case Control Study (ORAMICAL)

Periodontitis | Alzheimer Disease

France
Cognition Therapeutics
National Institute on Aging (NIA)

Active, not recruiting

Study to Evaluate the Safety, Tolerability and Efficacy of CT1812 in Subjects With Mild to Moderate Dementia With Lewy Bodies (COG1201)

Dementia With Lewy Bodies

United States
Moberg Pharma AB

Completed

Skin Irritation Potential of MOB015B in Healthy Subjects Using a Cumulative Irritant Patch Test Design (CIPT)

Erythema

United States
University of Zurich
Avid Radiopharmaceuticals; Swiss Federal Institute of Technology

Active, not recruiting

Imaging Tau Deposition in the Brain of Elderly Subjects (Add-Tau)

Healthy | Neurocognitive Disorders | Alzheimer Disease | Mild Cognitive Impairment

Switzerland
Centre Hospitalier Universitaire de Besancon
Novartis Pharmaceuticals; National Cancer Institute, France; National Research... and other collaborators

Terminated

Multicenter Prospective Cohort of Informal Caregivers in Burgundy and Franche-Comté (ICE)

Breast Cancer | Ischemic Stroke | Parkinson Disease | Age-related Macular Degeneration | Colorectal Cancer | Alzheimer Disease | Prostate Cancer | Hemorrhagic Stroke | Cardiac Disease

France
Alzamend Neuro, Inc.

Completed

Multiple Ascending Dose Safety, Tolerability, PK Study of AL001 in Alzheimer's Disease Patients & Healthy Adult Subjects ("MAD")

Alzheimer's Disease | Healthy Non-elderly and Elderly Adults

United States, Canada
Brigham and Women's Hospital
Johns Hopkins University; National Institute on Aging (NIA); Rutgers University

Active, not recruiting

Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Anastrozole vs Exemestane/Letrozole

Breast Cancer

United States
The University of Texas Health Science Center at...

Completed

Impact of Omega 3 Fatty Acid Supplementation on Aromatase in Obese Subjects

Breast Cancer

United States
Shanghai Hengrui Pharmaceutical Co., Ltd.

Completed

A Study of SHR-1707 in Healthy Young Adult and Elderly Subjects

Alzheimer's Disease

China
Cosmetique Active International

Completed

Evaluation of Cicaplast in Subjects With Skin Irritation

Skin Diseases

Mauritius, United States, China, Poland
ACADIA Pharmaceuticals Inc.

Completed

A Safety Study of Pimavanserin in Adult and Elderly Subjects Experiencing Neuropsychiatric Symptoms Related to Neurodegenerative Disease

Neuropsychiatric Symptoms Related to Neurodegenerative Disease

United States, Russian Federation, Serbia, Poland, Georgia, Czechia, Bulgaria, Colombia, Mexico, Romania, South Africa, Ukraine
Atridia Pty Ltd.

Completed

A Trial of SHR-1707 in Healthy Young Adult and Elderly Subjects

Alzheimer Disease

Australia
PharmaEssentia
PharmaEssentia Japan K.K.

Completed

Safety Evaluation of KX01 Ointment 1% in Japanese Healthy Male Subjects

Healthy Volunteer

Japan
Galderma R&D

Completed

Adjunctive Usage of a Moisturizing Lotion (Cetaphil® Moisturizing Lotion) to Limit the Skin Irritation Linked to the Set-Up of a Treatment by Topical Retinoid (Differin® Gel 0,1%) in Healthy Subjects of Chinese Origins

Healthy Skin

Singapore
Merck Sharp & Dohme LLC

Completed

A Long-Term Safety Study of Org 50081 (Esmirtazapine) in Elderly Outpatients With Chronic Primary Insomnia (176005/P05697/MK-8265-001) (Jade)

Dyssomnias | Sleep Disorders | Mental Disorder | Sleep Initiation and Maintenance Disorder; Elderly | Sleep Disorder, Intrinsic
Axovant Sciences Ltd.

Completed

Study Evaluating Intepirdine (RVT-101) on Gait and Balance in Subjects With Dementia

Alzheimer's Disease | Dementia With Lewy Bodies | Parkinson's Disease Dementia

United States
LEO Pharma

Completed

Skin Irritation of LEO 90100 Foam (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Healthy Japanese Subjects

Psoriasis Vulgaris

Japan
Gregory Jicha, 323-5550
University of Kentucky; Kentucky Alzheimer's Center

Completed

Valproic Acid in Subjects With Intact Cognition - Proof of Concept Study (VPA)

Alzheimer's Disease

United States
AstraZeneca

Completed

SAD/MAD Study to Assess Safety, Tolerability, PK & PD of MEDI1814 in Subjects With Mild-Moderate Alzheimer's Disease.

Healthy Elderly | Mild-Moderate Alzheimer's Disease

United States
Institute for Neurodegenerative Disorders

Terminated

Evaluation of [18F] PBR06 and PET as a Marker of Inflammation in Subjects With Neurological Conditions (PBR06)

Multiple Sclerosis | Parkinson Disease | Alzheimer Disease

United States
Institute for Neurodegenerative Disorders

Terminated

Evaluation of [123I]CLINDE and SPECT as a Marker of Inflammation in Subjects With PD or AD and in Healthy Subjects (CLINDE)

Multiple Sclerosis | Parkinson Disease | Alzheimer Disease | Healthy Controls

United States
GlaxoSmithKline

Completed

Safety and Immunogenicity of the Zoster Vaccine GSK1437173A in Elderly Subjects

Herpes Zoster

Germany, Czechia, Sweden, Netherlands
GlaxoSmithKline

Completed

To Investigate Primary Irritation Potential of Four Skin Serum Products on Human Subjects Assessed by 24 Hour Patch Test

Skin Care

Brazil
Pfizer
Medivation, Inc.

Completed

A Phase 1, Randomized, Open-Label, Two-Way Crossover Study To Evaluate The Steady-State Effect Of Dimebon (PF 01913539) On The Single-Dose Pharmacokinetics And Pharmacodynamics Of Warfarin In Healthy Subjects

Alzheimer's Disease | Huntington's Disease

United States
Pfizer

Completed

Clinical Trial In Healthy Volunteers And Health Elderly Volunteers To Evaluate The Safety, Tolerability And Blood Concentration After Single And Multiple Escalating Oral Doses Of PF-06751979.

Healthy Subjects

Belgium
Church & Dwight Company, Inc.

Completed

14-Day Cumulative Irritation Patch Test in Subjects With Normal Skin - Chameleon

Dermal Irritation

United States
Stiefel, a GSK Company
GlaxoSmithKline

Completed

A Study to Evaluate the Irritation Potential of Tazarotene Foam on Skin in Healthy Volunteers

Acne Vulgaris

United States
Stiefel, a GSK Company

Completed

A Study to Evaluate the Irritation Potential of GSK2894512 Cream on Skin in Healthy Subjects

Psoriasis

United States, Germany
GlaxoSmithKline

Terminated

GSK2647544 RD, DDI in Healthy Young and Elderly Volunteers

Alzheimer's Disease

United Kingdom
Bial - Portela C S.A.

Completed

Pharmacokinetic Profile of BIA 6-512 in Healthy Elderly Subjects Versus Healthy Young Subjects

Parkinson Disease

Germany
Heptares Therapeutics Limited
P1vital Limited

Completed

Phase 1 Study Investigating Effects of HTL0009936 on Cognition and BOLD fMRI Signals in Healthy Elderly Subjects

Alzheimer's Disease

United Kingdom
Tetra Discovery Partners

Completed

A Multiple Ascending Dose Study of BPN14770 in Healthy Young and Elderly Male or Female Subjects

Alzheimer's Disease

United States
Institute for Neurodegenerative Disorders

Completed

A PET Brain Imaging Study of mGluR5 in Subjects With Neuropsychiatric Conditions (FPEB)

Parkinson Disease | Alzheimer Disease | Mild Cognitive Impairment | Fragile X Syndrome | Huntington Disease | Autistic Spectrum Disorders

United States
Molecular NeuroImaging
Institute for Neurodegenerative Disorders

Completed

Evaluation of [18F]MNI-777 PET as a Marker of Tau Pathology in Subjects With Tauopathies Compared to Healthy Subjects

Alzheimer's Disease (AD) | Tauopathies | Parkinson's Disease (PD) | Progressive Supranuclear Palsy (PSP) | Chronic Traumatic Encephalopathy (CTE) | Frontal Temporal Dementia (FTD) | Pick's Disease

United States
Church & Dwight Company, Inc.

Completed

14-Day Cumulative Irritation Patch Test in Subjects With Normal Skin

Cumulative Irritation

United States
LEO Pharma

Completed

Skin Irritation Test of LEO 80185 Gel in Healthy Japanese Subjects

Skin and Connective Tissue Diseases

Japan
Merck Sharp & Dohme LLC

Completed

A Study to Assess Regional Cerebral Blood Flow as an Alzheimer's Disease Biomarker Compared to Positron Emission Tomography in Patients With Mild-to-Moderate Alzheimer's Disease and Cognitively Normal Elderly Subjects (Study MK-0000-068)(COMPLETED)

Alzheimer's Disease
LEO Pharma
Quintiles, Inc.

Completed

A Study Evaluating Skin Irritation, Phototoxicity and Safety After Administration of LEO 90105 on Intact Skin of Healthy Japanese Male Subjects

Healthy

Japan
Solvay Pharmaceuticals

Terminated

Treatment of Elderly Subjects With Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's Type

Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's Type

United States, Czech Republic, Estonia, Israel, Poland
Bial - Portela C S.A.

Completed

Pharmacokinetics of BIA 9-1067 and Its Metabolites in Healthy Male Elderly Subjects and in Healthy Male Young Subjects

Parkinson Disease

France
Theravance Biopharma

Completed

Safety, Pharmacokinetics and Pharmacodynamics of Velusetrag in Healthy Elderly Subjects

Alzheimer's Disease

United States
KineMed
Bristol-Myers Squibb

Completed

Evaluating Cerebrospinal Fluid Biomarkers in Alzheimer's, Progressive Supranuclear Palsy Subjects, and Controls

Alzheimer Disease | Progressive Supranuclear Palsy

United States
Yale University
National Institute on Aging (NIA)

Completed

Guanfacine Treatment for Prefrontal Cognitive Dysfunction in Elderly Subjects

Cognitive Aging

United States
Institute for Neurodegenerative Disorders

Completed

Research Involving Subjects With Parkinson's Disease, Alzheimer Disease and Healthy Controls

Parkinson Disease | Alzheimer Disease

United States
Institute for Neurodegenerative Disorders

Completed

Evaluation of 123-I Iodobenzovesamicol (IBVM) and SPECT Imaging of Healthy Subjects and Patients With Alzheimer Disease (IBVM001)

Parkinson Disease | Alzheimer Disease

United States
Mundipharma AB

Completed

Norspan Efficacy and Safety Among Elderly Subjects

Osteoarthritis Pain of the Hip and or Knee

Sweden
Targacept Inc.

Completed

Multiple Ascending Dose Study of TC-5619 in Healthy Elderly Subjects and Subjects With Alzheimer's Disease

Alzheimer's Disease

United States

Search clinical trials for: Skin Irritation in elderly Alzheimer's subjects

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Austria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations